Secondary Prophylaxis of CMV Infection Using Letermovir After HID-HSCT

Clinical trial NCT05914701 · UNKNOWN

Trial details

NCT number: NCT05914701
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

To Evaluate the Efficacy and Safety of Secondary Prophylaxis of CMV Reactivation

Start date: 2023-07-01
Primary completion: 2024-12-31
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.